Pro Share Advisors LLC Relay Therapeutics, Inc. Transaction History
Pro Share Advisors LLC
- $39.7 Billion
- Q3 2024
A detailed history of Pro Share Advisors LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 26,708 shares of RLAY stock, worth $125,527. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,708
Previous 20,883
27.89%
Holding current value
$125,527
Previous $136,000
38.97%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$131 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$49.6 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$43.5 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$34.7 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $565M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...